Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRON NYSE:RIV NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.67+3.5%$2.35$1.60▼$2.77$987.86M1.132.64 million shs1.99 million shsRIVRiverNorth Opportunities Fund$11.95-0.7%$12.32$10.11▼$12.96N/AN/A87,590 shs220,141 shsTLRYTilray Brands$1.26+5.9%$0.96$0.35▼$1.85$1.31B2.0357.42 million shs49.60 million shsUSNAUSANA Health Sciences$30.83+2.2%$30.89$23.10▼$41.83$551.44M0.64116,274 shs109,835 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group+3.49%+3.49%+7.66%+43.55%+17.62%RIVRiverNorth Opportunities Fund-0.94%-1.40%-2.96%-0.58%-3.43%TLRYTilray Brands+5.88%+18.87%+18.87%+250.00%-30.00%USNAUSANA Health Sciences+2.39%-0.08%-0.44%+0.86%-22.58%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.67+3.5%$2.35$1.60▼$2.77$987.86M1.132.64 million shs1.99 million shsRIVRiverNorth Opportunities Fund$11.95-0.7%$12.32$10.11▼$12.96N/AN/A87,590 shs220,141 shsTLRYTilray Brands$1.26+5.9%$0.96$0.35▼$1.85$1.31B2.0357.42 million shs49.60 million shsUSNAUSANA Health Sciences$30.83+2.2%$30.89$23.10▼$41.83$551.44M0.64116,274 shs109,835 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group+3.49%+3.49%+7.66%+43.55%+17.62%RIVRiverNorth Opportunities Fund-0.94%-1.40%-2.96%-0.58%-3.43%TLRYTilray Brands+5.88%+18.87%+18.87%+250.00%-30.00%USNAUSANA Health Sciences+2.39%-0.08%-0.44%+0.86%-22.58%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRONCronos Group 0.00N/AN/AN/ARIVRiverNorth Opportunities Fund 0.00N/AN/AN/ATLRYTilray Brands 2.33Hold$1.9453.77% UpsideUSNAUSANA Health Sciences 2.00Hold$36.0016.77% UpsideCurrent Analyst Ratings BreakdownLatest USNA, CRON, TLRY, and RIV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/25/2025TLRYTilray BrandsJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$1.50 ➝ $2.007/29/2025TLRYTilray BrandsZelman & AssociatesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 9/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRONCronos Group$117.61M8.69$0.00 per share5,544.57$2.90 per share0.92RIVRiverNorth Opportunities Fund$36.29MN/AN/AN/AN/AN/ATLRYTilray Brands$210.48M6.59$0.15 per share8.23$1.40 per share0.90USNAUSANA Health Sciences$854.50M0.66$3.85 per share8.00$27.92 per share1.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRONCronos Group$41.08M$0.0553.4089.00N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)RIVRiverNorth Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)USNAUSANA Health Sciences$42.03M$1.8017.1310.670.963.79%9.48%6.95%10/28/2025 (Estimated)Latest USNA, CRON, TLRY, and RIV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/9/2025Q1 2026TLRYTilray Brands-$0.03N/AN/AN/A$205.75 millionN/A8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 million7/22/2025Q2 2025USNAUSANA Health Sciences$0.54$0.74+$0.20$0.52$225.20 million$235.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRONCronos GroupN/AN/AN/AN/AN/ARIVRiverNorth Opportunities Fund$1.5312.80%N/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ALatest USNA, CRON, TLRY, and RIV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.56%9/15/20259/15/20259/30/20257/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.36%8/15/20258/15/20258/29/20257/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.48%7/15/20257/15/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRONCronos GroupN/A24.6523.53RIVRiverNorth Opportunities FundN/AN/AN/ATLRYTilray Brands0.202.461.49USNAUSANA Health SciencesN/A2.151.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRONCronos Group8.71%RIVRiverNorth Opportunities FundN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCRONCronos Group7.30%RIVRiverNorth Opportunities FundN/ATLRYTilray Brands0.60%USNAUSANA Health Sciences0.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRONCronos Group450382.89 million354.94 millionOptionableRIVRiverNorth Opportunities FundN/AN/AN/ANot OptionableTLRYTilray Brands2,8421.10 billion1.09 billionOptionableUSNAUSANA Health Sciences1,70018.27 million18.16 millionOptionableUSNA, CRON, TLRY, and RIV HeadlinesRecent News About These CompaniesUSANA Health Sciences (NYSE:USNA) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?September 17 at 3:17 AM | marketbeat.comUSNA vs. STVN: Which Stock Is the Better Value Option?September 15, 2025 | zacks.comIs USANA Health Sciences (USNA) a Great Value Stock Right Now?September 15, 2025 | zacks.comUSANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven ResultsSeptember 11, 2025 | prnewswire.comUSANA Health Sciences, Inc. $USNA Shares Acquired by Jacobs Levy Equity Management Inc.September 11, 2025 | marketbeat.comPetrus Trust Company LTA Takes Position in USANA Health Sciences, Inc. $USNASeptember 10, 2025 | marketbeat.com5 Undervalued Stocks That Are Worth Buying in SeptemberSeptember 9, 2025 | zacks.comUSANA Expands Its Nutritionals Line With Powerful New Products and Enhanced FormulasSeptember 9, 2025 | prnewswire.com12,828 Shares in USANA Health Sciences, Inc. $USNA Bought by Walleye Capital LLCSeptember 6, 2025 | marketbeat.comMagnetar Financial LLC Purchases New Holdings in USANA Health Sciences, Inc. $USNASeptember 4, 2025 | marketbeat.comNuveen LLC Makes New Investment in USANA Health Sciences, Inc. $USNASeptember 4, 2025 | marketbeat.comKevin Guest Encourages Self-Improvement as Path to Harmony, FulfillmentSeptember 2, 2025 | prnewswire.comCharles Schwab Investment Management Inc. Increases Stock Position in USANA Health Sciences, Inc. $USNAAugust 31, 2025 | marketbeat.comAmerican Century Companies Inc. Has $6.88 Million Stock Position in USANA Health Sciences, Inc. $USNAAugust 30, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Holdings in USANA Health Sciences, Inc. $USNAAugust 29, 2025 | marketbeat.comUSNA or STVN: Which Is the Better Value Stock Right Now?August 28, 2025 | zacks.comVersor Investments LP Buys New Stake in USANA Health Sciences, Inc. $USNAAugust 24, 2025 | marketbeat.comUSANA Introduces New and Upgraded Products, Along with Its Health Professional Advisory CouncilAugust 22, 2025 | prnewswire.com4 Value Stocks Every Investor Should Hold in Volatile TimesAugust 21, 2025 | zacks.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?August 21, 2025 | zacks.comValue Investing: 5 Undervalued Stocks Worth Adding to Your PortfolioAugust 21, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Tilray's High Hopes: The Catalyst Driving Cannabis StocksBy Jeffrey Neal Johnson | August 21, 2025Why Micron Stock Could Outperform NVIDIA in 2025By Gabriel Osorio-Mazilli | September 12, 2025USNA, CRON, TLRY, and RIV Company DescriptionsCronos Group NASDAQ:CRON$2.67 +0.09 (+3.49%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$2.66 -0.01 (-0.37%) As of 09/18/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.RiverNorth Opportunities Fund NYSE:RIV$11.95 -0.09 (-0.75%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$11.96 +0.01 (+0.08%) As of 09/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.Tilray Brands NASDAQ:TLRY$1.26 +0.07 (+5.88%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$1.26 +0.00 (+0.40%) As of 09/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$30.83 +0.65 (+2.15%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$30.70 -0.13 (-0.44%) As of 09/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything Bloom Energy Booms on AI Power Demand and Analyst Upgrades Can Apple’s iPhone 17 and AI Push Its Stock to New Highs? Why Seagate Is Wall Street's New Favorite AI Infrastructure Play New Catalysts Build Positive Pressure on Intel Stock Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why General Mills Is a Generational Opportunity for Income Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
